Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05624528
PHASE2
A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder
Sponsor: University of Chicago
View on ClinicalTrials.gov
Summary
The primary aim of the present study is to examine the efficacy and safety of tolcapone in adults with moderate to severe OCD.
Official title: A Double-Blind, Randomized, Placebo-Controlled Study of Tolcapone for OCD
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
49
Start Date
2023-06-22
Completion Date
2026-06
Last Updated
2026-03-10
Healthy Volunteers
No
Conditions
Interventions
DRUG
Tolcapone
catechol-O-methyl transferase inhibitor
DRUG
Placebo
Pill that contains no medicine
Locations (1)
University of Chicago Medical Center
Chicago, Illinois, United States